NFKB1 and breast cancer: On the other hand, studies have shown that ginsenoside Rh1 increases the production of mtROS to induce mitochondrial dysfunction, thereby inhibiting STAT/NF-κB signaling pathway, which in turn inhibits migration, invasion of BC cells, as well as angiogenesis (Jin et al., 2021).